Effect of SGLT-2 inhibitors on liver fibrosis progression in patients with MASLD: an updated meta-analysis based on RCTs
SGLT-2 inhibitors may delay the progression of liver fibrosis in patients with MASLD, particularly by improving serologic parameters. However, additional high-quality studies are needed to validate their clinical value.
Authors
- Anyi Xu (ORCID: https://orcid.org/0009-0004-7231-3994)
- Jiale Ruan
- Yingying Fang
- Lei Yang
Institutions
- Zhejiang Chinese Medical University (CN)
- Integrated Chinese Medicine (China) (HK)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-20
- DOI
- https://doi.org/10.3389/fmed.2025.1667823
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00